Efficacy of Topical Hydrocortisone in Combination with Topical Ciclosporin A for the Treatment of Dry Eye Disease in Patients with Sjögren Syndrome

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Age (years)</td><td class="align_center">62.3 ± 18.5</td></tr><tr><td class="align_left" colspan="2"><hr/></td></tr><tr><td class="align_left">Sex (m: f)</td><td class="align_center">2 : 10</td></tr><tr><td class="align_left" colspan="2"><hr/></td></tr><tr><td class="align_left">Sjögren syndrome (primary: secondary)</td><td class="align_center">3 : 9</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Demographic data of the study population.</div>

Journal of Ophthalmology

tab1

Table 1

Table 1: Efficacy of Topical Hydrocortisone in Combination with Topical Ciclosporin A for the Treatment of Dry Eye Disease in Patients with Sjögren Syndrome 

Table 1 | Efficacy of Topical Hydrocortisone in Combination with Topical Ciclosporin A for the Treatment of Dry Eye Disease in Patients with Sjögren Syndrome 